Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: 2015 | 2010 | 2009 | 2006 | 2003 | 2002 | 1997 | 1995 | 1994

2015

Chemosensitization by diverging modulation by short-term and long-term TNF-α action on ABCB1 expression and NF-κB signaling in colon cancer.
Walther, W. and Kobelt, D. and Bauer, L. and Aumann, J. and Stein, U.
International Journal of Oncology 47 (6): 2276-2285. December 2015

2010

Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.
Adema, A.D. and Laan, A.C. and Myhren, F. and Fichtner, I. and Verheul, H.M. and Sandvold, M.L. and Peters, G.J.
International Journal of Oncology 36 (1): 285-294. 1 January 2010

2009

Localization of telomerase hTERT protein in frozen sections of basal cell carcinomas (BCC) and tumor margin tissues.
Fabricius, E.M. and Kruse-Boitschenko, U. and Khoury, R. and Wildner, G.P. and Raguse, J.D. and Klein, M. and Hoffmeister, B.
International Journal of Oncology 35 (6): 1377-1394. December 2009

Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models.
Bracker, T.U. and Sommer, A. and Fichtner, I. and Faus, H. and Haendler, B. and Hess-Stumpp, H.
International Journal of Oncology 35 (4): 909-920. October 2009

Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Fabricius, E.M. and Kruse-Boitschenko, U. and Khoury, R. and Wildner, G.P. and Raguse, J.D. and Klein, M.
International Journal of Oncology 34 (5): 1257-1279. May 2009

2006

The tumour-Clostridium phenomenon: 50 years of developmental research.
Schmidt, W. and Fabricius, E.M. and Schneeweiss, U.
International Journal of Oncology 29 (6): 1479-1492. 1 December 2006

Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo.
Michaelis, M. and Fichtner, I. and Behrens, D. and Haider, W. and Rothweiler, F. and Mack, A. and Cinatl, J. and Doerr, H.W. and Cinatl, J.
International Journal of Oncology 28 (2): 439-446. February 2006

2003

Clinical significance of telomerase activity in basal cell carcinomas and in tumour-free surgical margins.
Fabricius, E.M. and Bezeluk, A. and Kruse-Boitschenko, U. and Wildner, G.P. and Klein, M.
International Journal of Oncology 23 : 1389-1399. 1 November 2003

2002

Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells.
Krasagakis, K. and Fimmel, S. and Genten, D. and Eberle, J. and Quas, P. and Ziegler, W. and Haller, H. and Orfanos, C.E.
International Journal of Oncology 20 : 865-871. 1 January 2002

1997

Bromelain proteases suppress growth, invasion and lung metastasis of B16F10 mouse melanoma cells.
Grabowska, E. and Eckert, K. and Fichtner, I. and Schulze-Forster, K. and Maurer, H.R.
International Journal of Oncology 11 : 243-248. 1 January 1997

Expression of E-cadherin/catenin complexes in breast cancer: correlation with favourable prognostic factors and survival.
Schoenborn, I. and Zschiesche, W. and Behrens, J. and Herrenknecht, K. and Birchmeier, W.
International Journal of Oncology 11 : 1327-1334. 1 January 1997

1995

Influence of retrovirally transduced human tumor-necrosis-factor-alpha on the expression of C-myc, k-ras, C-jun, p53, tgf-alpha, and cea in human colon-carcinoma cell-lines.
Uckert, W. and Walther, W. and Hummel, O.
International Journal of Oncology 6 : 1027-1031. 1 January 1995

1994

Induction of differentiation of human myeloid leukemic K562 cells by 3'-deoxy-3'-fluorothymidine (comparison with arabinosylcytosine).
Eckert, K. and Fuhrmannselter, T. and Schuett, M. and Langen, P. and Maurer, H.R.
International Journal of Oncology 4 : 853-858. 1 January 1994

Amplification of satellite DNA at 16q11.2 in the germ line of a patient with breast cancer.
Savelyeva, L. and Schneider, B. and Finke, L.H. and Schlag, P.M. and Schwab, M.
International Journal of Oncology 4 : 347-351. 1 January 1994

Wild-Type p53 is not involved in reversion of the tumorigenic phenotype of breast cancer cells after transfer of normal chromosome 17.
Theile, M. and Hartmann, S. and Naundorf, H. and Ruebeta, D. and Elbe, B. and Krause, H. and Deppert, W. and Barrett, J.C. and Scherneck, S.
International Journal of Oncology 4 : 1067-1075. 1 January 1994

Influence of different promoters on the expression of tumor necrosis factor alpha in LS174T human colon carcinoma cells.
Uckert, W. and Asche, O. and Mahanty, B. and Fichtner, I.
International Journal of Oncology 5 : 865-871. 1 January 1994

This list was generated on Wed Dec 12 02:25:25 2018 CET.
Open Access
MDC Library